Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.
about
Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesNailfold capillaroscopy in pediatricsDuration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis.The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy.Mycophenolate mofetil: a possible therapeutic agent for children with juvenile dermatomyositis.Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.DNA methylation dynamics in muscle development and disease.Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis.Ovarian teratoma mimicking features of juvenile dermatomyositis in a child.Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis.Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cellsJuvenile dermatomyositis: new insights and new treatment strategies.The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity.Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126.Association of nailfold capillary changes with disease activity, clinical and laboratory findings in patients with dermatomyositisBrief Report: Association of Myositis Autoantibodies, Clinical Features, and Environmental Exposures at Illness Onset With Disease Course in Juvenile Myositis.The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomesElevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy.Juvenile dermatomyositis calcifications selectively displayed markers of bone formation.Recurrence of juvenile dermatomyositis 8 years after remission.Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease.Measuring outcomes in systemic lupus erythematosus clinical trials.Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot studyEvaluation of the reliability of the Cutaneous Dermatomyositis Disease Area and Severity Index and the Cutaneous Assessment Tool-Binary Method in juvenile dermatomyositis among paediatric dermatologists, rheumatologists and neurologists.Mast cells and type I interferon responses in the skin of patients with juvenile dermatomyositis: are current therapies just scratching the surface?Nailfold capillary density is importantly associated over time with muscle and skin disease activity in juvenile dermatomyositis.Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset.Nailfold capillaroscopy in systemic sclerosis: is there any difference between videocapillaroscopy and dermatoscopy?Juvenile dermatomyositis management: moving but in need of a push.Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis.Aerobic fitness after JDM--a long-term follow-up study.Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.The Vasculopathy of Juvenile DermatomyositisClinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study
P2860
Q26863125-E1698F6E-9FB9-4CFC-AFAB-4F93BA7D9BC4Q27006752-42A32542-2749-4795-A85E-3A0F1BCAC044Q33356785-AD84E3AF-9E9F-4FB9-836C-756F918DB698Q33694683-CFB84D5A-7CC6-4BD6-AD2A-A6DCD44165CAQ33932460-96405413-55D3-4F54-8ACB-EC05270FCE3DQ34185599-F4C9C3F3-DA3F-4417-804C-572ECACC6C9FQ34310736-6EC68D0F-B633-4B75-863F-25003C81FCF8Q35009335-62ED49C7-6104-4920-BB14-4DBCE73DB3CBQ35149910-D4D183DF-3FB4-4B29-8D7E-9375D14CB323Q35349884-8922EC42-B444-4C25-A243-C769B4E36F7FQ35530037-CCF35BD1-D21B-49EB-9B8E-4A8F92ED1B68Q35832819-F412747D-AEC9-4F25-B1E0-C164F67B1BF3Q35854122-929CE3C2-A5FB-4D55-A4C3-9647779D99ADQ36059542-8044F266-C9C5-4ECC-923D-303B1C70045EQ36086954-ACA4B4E5-E49E-4D8D-94E6-1A50E1BE43A1Q36291269-A0737BCF-5D19-4373-B7D5-9B660FF5CC4CQ36312962-0E480CBA-88A8-4923-9431-8AD65D9BF3E7Q36469290-5DDFAA5C-8C3C-4AF9-B77B-6CD751152C67Q36619819-7EBFD0DD-E12D-478B-8755-A5EDBF7A0B86Q37022721-7AA998D8-BB40-4484-BE6D-43077ADB8F9DQ37229729-E545FFCE-FD31-44EE-B79A-73A27485B378Q37340576-372669CB-3BE1-44C9-A164-A131EE0171D7Q37539217-6FAA9753-2590-4CEF-84AB-86CD4EA9B309Q37579105-FC3B6216-C220-4E46-92A9-30FAD13A9F82Q37914899-EF71FE79-8AF2-4061-9545-FC41535A528CQ38534871-FC817FFA-3C37-4F15-8257-CEEC2150C1CFQ38780346-049103E7-C6F1-4B8E-9078-CD456336533EQ38831077-BFDED699-930C-4D4B-90B1-B5D50EF50C43Q42418314-6B2C0817-0B07-46D0-B7A4-E6985212F0C1Q43633796-81C4E64C-4FF5-466F-B234-D982B0E327A7Q43863286-335862A6-2F53-4FD2-9ED6-5E6FDD5B3506Q44797000-B1B41C47-C241-493A-913B-495CF52FFD0BQ46038308-2B6FDA72-29D1-4E3C-84D5-B643DF782ECCQ46134512-6BE708B0-398E-484A-BD7C-C56D5AE8899EQ46892973-57701795-73D3-4084-86B2-3C79512690E2Q47689325-119C26F9-BDBF-46D5-A5B1-986ABA901AF6Q57816912-DDD5BD19-CF94-4A89-ABED-044DE302F9B9Q58778034-01D1ABCB-FC27-49BF-8517-FA13BD5ADB09
P2860
Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Persistent association of nail ...... with juvenile dermatomyositis.
@ast
Persistent association of nail ...... with juvenile dermatomyositis.
@en
type
label
Persistent association of nail ...... with juvenile dermatomyositis.
@ast
Persistent association of nail ...... with juvenile dermatomyositis.
@en
prefLabel
Persistent association of nail ...... with juvenile dermatomyositis.
@ast
Persistent association of nail ...... with juvenile dermatomyositis.
@en
P2093
P2860
P356
P1476
Persistent association of nail ...... with juvenile dermatomyositis
@en
P2093
Joyce Sundberg
Lauren M Pachman
Roopa Seshadri
Stéphanie Christen-Zaech
P2860
P304
P356
10.1002/ART.23299
P577
2008-02-01T00:00:00Z